Avoro Capital Advisors’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-419,580	Closed	-$28.6M	–	42
2024 Q1	$28.6M	Buy	+419,580	New	+$28.6M	0.33%	42
2018 Q4	–	Sell	-147,368	Closed	-$6.54M	–	38
2018 Q3	$6.54M	Buy	+147,368	New	+$6.54M	0.3%	34